Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06261580 · ClinicalTrials.gov registry record
Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers
A clinical trial of Healthy, sponsored by Haemonetics Corporation.
- Completed
- Registry status
- 181
- Enrollment target
- 3
- Study locations
NCT06261580 is a study of Healthy that has completed, run by Haemonetics Corporation. The registered enrollment target is 181 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (72% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06261580, a study of Healthy, has completed, sponsored by Haemonetics Corporation.
- COMPLETED
- Registry status
- 181 participants
- Enrollment target
- 3
- Study locations
Study Summary
This trial holds minimal risk to the trial volunteers and consists of obtaining whole blood via venipuncture to perform coagulation parameter measurements to define a Normal Reference Range. Written consent to participate in the study will be obtained prior to volunteer screening per site procedures.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST TEG 6s Citrated K, KH, RTH, and FFH Cartridge
- DIAGNOSTIC_TEST Clauss Fibrinogen
Study Locations (3)
California
- Machaon Diagnostics - Oakland
Illinois
- Cardiovascular Research Institute - Loyola University Chicago Health Sciences - Maywood
Louisiana
- Louisiana Coagulation / Machaon Division - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2021-07-28 |
| Est. Completion | 2021-10-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06261580
The ClinicalTrials.gov registry entry for NCT06261580 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (72% lower). The listed sponsor is Haemonetics Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which TEG 6s Citrated K, KH, RTH, and FFH Cartridge is the first listed.
NCT06261580 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, Louisiana.
Frequently Asked Questions
What is clinical trial NCT06261580 about?
NCT06261580 is a clinical study titled "Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers". This trial holds minimal risk to the trial volunteers and consists of obtaining whole blood via venipuncture to perform coagulation parameter measurements to define a Normal Reference Range. Written consent to participate in the study will be obtained prior to volunteer screening per site procedure...
What is the current status of trial NCT06261580?
This trial is currently completed. The enrollment target is 181 participants. The study started on 2021-07-28. Estimated completion is 2021-10-25.
What conditions does trial NCT06261580 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT06261580?
The interventions under investigation include: TEG 6s Citrated K, KH, RTH, and FFH Cartridge (DIAGNOSTIC_TEST), Clauss Fibrinogen (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06261580?
This trial is sponsored by Haemonetics Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06261580 being conducted?
This trial has 3 study locations across California, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.